Spinraza

Active Ingredient(s): Nusinersen
FDA Approved: * December 23, 2016
Pharm Company: * BIOGEN
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Spinraza Overview

Nusinersen (INN),[1] marketed as Spinraza,[3] is a biologic drug used in treating spinal muscular atrophy (SMA),[4] a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder. Contents 1 Medical use 2 Side effects 3 Pharmacology 4 Chemistry 5 History 6 Society and culture 7 References 8 Further reading Medical use The drug is used to treat spinal muscular atrophy associated with a mutation in the SMN1 gene. It is administered ...

Read more Spinraza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nusinersen

Recent Spinraza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nusinersen
  • Injection: 2.4mg/ml
  • Solution: 12mg/5ml (2.4mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Spinraza: (1 result)

Sorted by National Drug Code
  • 64406-058 Spinraza 2.4 mg/ml Intrathecal Injection, Solution by Biogen

Other drugs which contain Nusinersen or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 27 June 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.